D-1057-2017 Class II Terminated
FDA drug recall D-1057-2017 was initiated by PD-Rx Pharmaceuticals, Inc. on Jul 28, 2017 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification: out of specification for tablet weight. The recall status is terminated (terminated Dec 6, 2017). Affected quantity: 100 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 9, 2017
- Initiation Date
- Jul 28, 2017
- Termination Date
- Dec 6, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 100 bottles
Product description
Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30
Reason for recall
Failed Tablet/Capsule Specification: out of specification for tablet weight.
Distribution pattern
Nationwide
Code information
Lot: A17F55 Exp. 06/30/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1057-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026